Should all trials have a Data Safety and Monitoring Committee?☆☆☆
To access this article, please choose from the options below
☆ Reprint requests: John A. Cairns, MD, University of British Columbia, 317-219 Health Sciences Hall, Vancouver, British Columbia V6T 1Z3, Canada. E-mail: jacairns@medd.med.ubc.ca
☆☆ Am Heart J 2001;141:156-63
PII: S0002-8703(01)98656-9
doi:10.1067/mhj.2001.112501
© 2001 Mosby, Inc. All rights reserved.
